Attenutation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice

Brain Research

Volumn 743, Issue 1-2, 1996, Pages 17-23

  Lutfy, Kabirullah ^a,b   Weber, Eckard ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Pharmacokinetics and Drug Metabolism   (United States)

Author keywords

antinociception; formalin test; intrathecal; NMDA receptor glycine site; non NMDA receptor; tail flick assay

Indexed keywords

6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; FORMALDEHYDE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST; ANIMAL; ANIMAL BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; INTRASPINAL DRUG ADMINISTRATION; MICROINJECTION; MOUSE STRAIN; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED STRAINS; MICROINJECTIONS; PAIN; PAIN MEASUREMENT; QUINOXALINES; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030300178     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01017-7     Document Type: Article

References (32)

1. Aanonsen, L.M. and Wilcox, G., Nociceptive action of excitatory amino acids in the mouse: Effects of spinally administered opioids, phencyclidine and sigma agonists, J. Pharmacol. Exp. Ther., 243 (1987) 9-19.
2. Abbott, F.V., Melzack, R. and Samuel, C., Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems, Exp. Neurol., 75 (1982) 644-651.
3. Battaglia, G. and Rustioni, A., Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey, J. Comp. Neurol, 277 (1988) 303-312.
4. Cahusac, P.M.B., Evans, R.H., Hill, R.G., Rodriquez, R.E. and Smith, D.A.S., The behavioural effects of an N-methyl-aspartate receptor antagonist following application to the lumbar spinal cord of conscious rats, Neuropharmacology, 23 (1984) 719-724.
5. Carter, A.J., Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination, J. Pharmacol. Exp. Ther., 269 (1994) 573-580.
6. Coderre, T.J. and Melzack, R., The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury, J. Neurosci., 12 (1992) 3665-3670.
7. Coderre, T.J. and Van Empel, I., The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests, Pain, 59 (1994) 345-352.
8. Coderre, T.J. and Van Empel, I., The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allostericglycine and polyamine sites, Pain, 59 (1994) 353-359.
9. D'Amour, F.E. and Smith, D.L., A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-79.
10. Dickenson, A.H. and Ayder, E., Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat, Neurosci. Lett., 121 (1991) 263-266.
11. 3H]glutamate-binding sites in rat central nervous system, J. Neurosci., 4 (1992) 2133-2144.
12. Haley, J.E., Sullivan, A.F. and Dickenson, A.H., Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat, Brain Res., 518 (1990) 218-226.
13. Hunskaar, S., Fasmer, O.B. and Hole, K., Formalin test in mice, a useful technique for evaluating mild analgesics, J. Neurosci. Methods, 14 (1985) 69-76.
14. Hylden, J.L.K. and Wilcox, G., Intrathecal morphine in mice: A new technique, Eur. J. Pharmacol., 67 (1980) 313-316.
15. Johnson, J.W. and Ascher, P., Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325 (1987) 529-531.
16. Kristensen, J.D., Karlsten, R., Gordh, T. and Berge, O.-G., The NMDA antagonist 3-(2-carboxypiperazine-4-yl)propyl-l-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat, Pain, 56 (1994) 59-67.
17. Litchfield, J.T. and Wilcoxon, F., A simplified method of dose-effects experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-113.
18. Lutfy, K., Keana, J.F.W. and Weber, E., ACEA-1011, a novel NMDA receptor/glycine site antagonist produces antinociception but not tolerance in the formalin test, NIDA Res. Monogr., 147 (1995) 220-233.
19. Millan, M.J. and Seguin, L., ( + )-HA-966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice, Eur. J. Pharmacol., 238 (1993) 445-447.
20. Murray, C.W., Cowan, A. and Larson, A.A., Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model, Pain, 44 (1991) 179-185.
21. Näsström, J., Karlsson, U. and Post, C., Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice, Eur. J. Pharmacol., 212 (1992) 21-29.
22. Näsström, J., Karlsson, U. and Berge, O-G. Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists, Brain Res., 623 (1993) 47-55.
23. Raigorodsky, G. and Urea G., Involvement of N-methyl-D-aspartate receptors in nociception and motor control in the spinal cord of the mouse: Behavioral, pharmacological and electrophysiological evidence, Neuroscience, 36 (1990) 601-610.
24. Ren, K., Williams, G.M., Hylden, J.L.K., Ruda, M.A. and Dubner, R., The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats, Eur. J. Pharmacol., 219 (1992) 235-243.
25. Rosland, J.H., Hunskaar, S. and Hole, K., The effect of diazepam on nociception in mice, Pharmacol Toxicol, 61 (1987) 111-115.
26. Ryan, S.M., Watkins, L.R., Mayer, D.J. and Maier, S.F., Spinal pain suppression mechanisms may differ for phasic and tonic pain, Brain Res., 334 (1985) 172-175.
27. Skilling, S.R., Smullin, D.H., Beitz, A.J., and Larson, A.A., Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation, J. Neurochem., 51 (1988) 127-132.
28. Tallarida, R.J. and Murray, R.B., Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag New York, 1987.
29. Vaccarino, A.L., Marek, P., Kest, B., Weber, E., Keana, J.F.W. and Liebeskind, J.C., NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin, Brain Res., 615 (1993) 331-334.
30. Wilcox, G.L., Excitatory neurotransmitters and pain. In M.R. Bond, J.E. Charlton and C.J. Woolf (Eds.), Proceedings of the VIth World Congress on Pain, 1991, pp. 97-117.
31. Woodward, R., Huettner, J.E., Guastella, J., Keana, J.F.W, and Weber, E., In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites, Mol. Pharmacol, 47 (1995) 568-581.
32. Yamamoto, T. and Yaksh, T.L., Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK-801, an NMDA antagonist, on the formalin test in the rat, Anesthesiology, 11 (1992) 757-763.